Trending News
News
News
Agendia Raises €25 Million and Receives Second FDA Clearance
ING, one of the largest bank-insurers, becomes a shareholder of Agendia.
News
Ipsogen Grants Exclusive License to Warnex to Market a Leukemia Molecular Diagnostic Service in Canada
Ipsogen grants Warnex exclusive rights to market a service for the diagnosis and the classification of a group of leukemias.
News
BSD Medical Obtains Patent License for Primary Breast Cancer Treatment System from Duke University
BSD Medical gains exclusive rights to Duke’s treatment system for primary breast cancer using hyperthermia therapy.
News
A Study by the MUHC and McGill University Opens a new Door to Understanding Cancer
Study provides a key to understand the mechanisms that trigger cancer cell growth that may prove crucial to develop more targeted treatments for cancer.
News
GeneNews Secures $2 Million for Development of Prostate Biomarkers
GeneNews signs agreement with an Asian Biomedical consortium to develop blood-based biomarkers for the detection and management of prostate diseases.
News
Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia into Clinical Practice
Xenomics’ diagnostic test developed for stratification of patients with AML has been implemented at CLIA approved BRT Laboratories.
News
Eden Biodesign and the University of Manchester Intellectual Property Limited Develop Innovative Treatment for Cancer
UMIP selects Eden Biodesign to provide a range of services for the development of therapeutic for treatment of macular degeneration and cancer.
News
Ensemble Discovery and Roche Initiate Research Collaboration to Apply new Diagnostic Technology to Optimize Cancer Therapy
Collaboration will enable analysis of critical drug target family in patient cancer biopsies and selection of appropriate therapy.
News
Curidium Joins the Personalized Medicine Coalition
Curidium Medica plc has announced that it has joined the US-based Personalized Medicine Coalition.
News
eXludus Joins BioIT Alliance to Speed Life Sciences Research on Clusters and Grids
eXludus will contribute leadership in accelerating time-to-discovery through processing of biomedical applications and data across clusters and Grids.
Advertisement